[Hong Kong pharmaceutical stocks expanded their gains, WuXi AppTec and other stocks rose more than 10%] On November 4, the Hong Kong pharmaceutical sector strengthened during the session, and stocks with gains of more than 10% emerged in a concentrated manner, with CXO and biotechnology leading the gains. Zhaoyan New Drugs (06127.HK) rose by 13%, WuXi AppTec (02359.HK) rose by approximately 12%, WuXi Biologics (02269.HK) rose by approximately 11.4%, Asymchem (06821.HK) rose by approximately 12.9%, and WuXi United (02268.HK) rose by approximately 12%, Biocytogen-B (02315.HK) rose by about 17.2%, GenScript Biotech (01548.HK) rose by about 11.2%, Rongchang Biologics (09995.HK) rose by about 10.6%, and Kelonbotei Biologics (06990.HK) rose by about 10.2%.